Kinea Bio is a patient-focused biotechnology company striving to accelerate the development of next-generation AAV-based gene therapies to treat neuromuscular diseases. Kinea is developing an integrated technology platform designed to address the most critical challenges facing the field of gene therapy, including novel targeting and gene regulation technologies, advanced engineered tissue modeling capabilities, and strategies that will enable delivery of larger, more functional therapeutic cargos that has previously been possible.
Company Details
- Employees
- 6
- Address
- The Most Critical Challenges Facing The Field Of Gene Therapy
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.kineabio.com
- Keywords
- biotechnology.
Kinea Bio Questions
Kinea Bio's website is http://www.kineabio.com
Kinea Bio's LinkedIn profile is https://www.linkedin.com/company/kineabio
Kinea Bio has
6 employees.
View email and phone details for 6
employees at Kinea Bio.
Kinea Bio's industry is
Biotechnology Research
Kinea Bio's top competitors are
Soundeats,
Curi Bio,
Kurve Therapeutics, Inc.,
Celogics,
Notch Therapeutics,
Küleon Bioscience,
Ignyte Bio,
Modulus Therapeutics,
Hdt Bio,
Kinea Investimentos.
Kinea Bio's categories are Biotechnology Research
